A new study in the Journal of the American College of Surgeons documents patients with stage II pancreatic cancer who are treated with chemotherapy followed by resection (an operation that removes the cancerous part of the organ, structure or tissue) live nearly twice as long as patients who receive only chemotherapy. Key findings are summarized by the study’s lead study author Amanda K. Arrington, MD, MHM, FACS, a surgical oncologist at the University of Arizona Department of Surgery, Tucson.
